Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003172353 | SCV003861661 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-01-26 | criteria provided, single submitter | clinical testing | The c.1152dupT pathogenic mutation, located in coding exon 10 of the NF1 gene, results from a duplication of T at nucleotide position 1152, causing a translational frameshift with a predicted alternate stop codon (p.R385Sfs*11). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Institute of Medical Genetics and Applied Genomics, |
RCV003235791 | SCV003932862 | pathogenic | Neurofibromatosis, type 1 | 2023-06-21 | criteria provided, single submitter | clinical testing |